152 related articles for article (PubMed ID: 3145663)
21. Bright light therapy stabilizes the antidepressant effect of partial sleep deprivation.
Neumeister A; Goessler R; Lucht M; Kapitany T; Bamas C; Kasper S
Biol Psychiatry; 1996 Jan; 39(1):16-21. PubMed ID: 8719121
[TBL] [Abstract][Full Text] [Related]
22. [Comparative evaluation of catecholamine and dopa content in dermatoses].
Broér BA
Lab Delo; 1980; (4):224-6. PubMed ID: 6155548
[No Abstract] [Full Text] [Related]
23. [The action of high-intensity light on catecholamine excretion in depressive patients].
Bozhko GKh; Tsaritsinskiĭ VI; Strelianaia EI; Taranskaia AD
Zh Nevrol Psikhiatr Im S S Korsakova; 1996; 96(1):58-60. PubMed ID: 8677722
[TBL] [Abstract][Full Text] [Related]
24. [Combination therapy using sertraline with sleep deprivation and light therapy compared to sertraline monotherapy for major depressive disorder].
Güdücü F; Caliyurt O; Vardar E; Tuğlu C; Abay E
Turk Psikiyatri Derg; 2005; 16(4):245-51. PubMed ID: 16362843
[TBL] [Abstract][Full Text] [Related]
25. [Various aspects of the differential therapy of circular depressions].
Prokhorova IS
Zh Nevropatol Psikhiatr Im S S Korsakova; 1985; 85(4):570-4. PubMed ID: 4002949
[TBL] [Abstract][Full Text] [Related]
26. [State of catecholamine and DOPA excretion in metabolic-alimentary obesity].
Frolova IA; Beiul EA; Volkova IS; Sirota II
Vopr Med Khim; 1974 May; 20(3):257-65. PubMed ID: 4836785
[No Abstract] [Full Text] [Related]
27. [Comparative characteristics of the effect of tricyclic antidepressants on the mechanisms of depressive states].
Sinitskiĭ VN; Usherenko LS; Kryzhanovskaia LA; Zapotochnyĭ BA
Fiziol Zh (1978); 1987; 33(4):61-9. PubMed ID: 3622815
[No Abstract] [Full Text] [Related]
28. [Hastening the onset of effects of tricyclic antidepressants by the use of bright white light].
Prasko J; Goldmann P; Zindr R; Zindr V
Cesk Psychiatr; 1987 Dec; 83(6):376-84. PubMed ID: 3442846
[No Abstract] [Full Text] [Related]
29. Partial sleep deprivation therapy combined with sertraline affects subjective sleep quality in major depressive disorder.
Caliyurt O; Guducu F
Sleep Med; 2005 Nov; 6(6):555-9. PubMed ID: 15994121
[TBL] [Abstract][Full Text] [Related]
30. [Evaluation of the effectiveness of electroshock therapy in patients with refractory depression].
Wasik A; Leszek J; Kiejna A; Juskowiak A
Psychiatr Pol; 1990; 24(2):111-5. PubMed ID: 2084714
[TBL] [Abstract][Full Text] [Related]
31. [Symptomatology of circular depression and prediction of the efficacy of treatment with tricyclic antidepressants].
Zaĭtsev SG; Prokhorova IS; Mikeshina NG; Gromova VV
Zh Nevropatol Psikhiatr Im S S Korsakova; 1983; 83(8):1198-1205. PubMed ID: 6624347
[TBL] [Abstract][Full Text] [Related]
32. [Catecholamine excretion and treatment of parkinsonism with midantan].
Kandel' EI; Iadgarov IS
Zh Nevropatol Psikhiatr Im S S Korsakova; 1976 Sep; 76(9):1323-6. PubMed ID: 1015136
[No Abstract] [Full Text] [Related]
33. [Modifications of catecholamine metabolism under the effect of a decarboxylase inhibitor associated with L-dopa and desipramine in patients with depressive and parkinsonian syndromes].
Geissbuhler F; Bartholini G; Gaillard JM; Tissot R
Encephale; 1971; 60(3):189-209. PubMed ID: 5119348
[No Abstract] [Full Text] [Related]
34. [Combined therapy with tricyclic and MAOI antidepressants in the treatment of resistant major depression].
Rosan TA; Mesones HL; Brengio F
Acta Psiquiatr Psicol Am Lat; 1994 Dec; 40(4):314-20. PubMed ID: 7484185
[TBL] [Abstract][Full Text] [Related]
35. [Catecholamine metabolism in various compensatory manifestations of epilepsy patients].
Golodets RG; Lando LI; Afanas'ev IuI
Zh Nevropatol Psikhiatr Im S S Korsakova; 1979; 79(3):324-8. PubMed ID: 442901
[TBL] [Abstract][Full Text] [Related]
36. [Excretion of catecholamines and DOPA in lipid metabolism disorders].
Frolova IA; Oleneva VA; Paramonova EG; Volkova IS; Sirota II
Vopr Med Khim; 1977; (6):797-803. PubMed ID: 595486
[TBL] [Abstract][Full Text] [Related]
37. [Every second patient with chronic pain is also depressive. Tricyclic antidepressants and cognitive behavior therapy are indicated].
Dumat W; Nutzinger DO
MMW Fortschr Med; 2000 Sep; 142(38):24-5. PubMed ID: 11050885
[No Abstract] [Full Text] [Related]
38. [Sleep deprivation as antidepressive treatment].
Kallestad H; Langsrud K; Hansen B
Tidsskr Nor Laegeforen; 2007 May; 127(10):1360-3. PubMed ID: 17519990
[TBL] [Abstract][Full Text] [Related]
39. [Use of L-DOPA in the complex treatment of severe craniocerebral injuries].
Piasetskaia MV; Bragina NN; Il'icheva RF; Potapov AA
Zh Nevropatol Psikhiatr Im S S Korsakova; 1987; 87(5):660-4. PubMed ID: 3113140
[TBL] [Abstract][Full Text] [Related]
40. [Catecholamine metabolism in Huntington's chorea (in patients and their phenotypically healthy relatives)].
Magalov ShI; Dadali EL
Zh Nevropatol Psikhiatr Im S S Korsakova; 1980; 80(8):1158-63. PubMed ID: 6452012
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
